IMMUCELL CORP /DE/ Quarterly Return On Equity in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immucell Corp /De/ quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q2 2024.
  • Immucell Corp /De/ Return On Equity for the quarter ending June 30, 2024 was -16.3 %, a 20.3% increase year-over-year.
  • Immucell Corp /De/ annual Return On Equity for 2023 was -21.8 %, a 180% decline from 2022.
  • Immucell Corp /De/ annual Return On Equity for 2022 was -7.79 %, a 3014% decline from 2021.
  • Immucell Corp /De/ annual Return On Equity for 2021 was -0.25 %, a 93% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -16.3 +4.16 +20.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.2 +2.09 +12.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -21.8 -14 -180% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22.6 -20.3 -880% Jul 1, 2023 Sep 30, 2023
Q2 2023 -20.5 -20.7 -13231% Apr 1, 2023 Jun 30, 2023
Q1 2023 -17.3 -20 -744% Jan 1, 2023 Mar 31, 2023
Q4 2022 -7.79 -7.54 -3014% Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.31 -2.43 -2017% Jul 1, 2022 Sep 30, 2022
Q2 2022 0.16 +1.65 Apr 1, 2022 Jun 30, 2022
Q1 2022 2.69 +7.46 Jan 1, 2022 Mar 31, 2022
Q4 2021 -0.25 +3.35 +93% Oct 1, 2021 Dec 31, 2021
Q3 2021 0.12 +5.45 Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.49 +4.4 +74.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -4.77 +0.58 +10.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -3.6 +0.79 +18% Oct 1, 2020 Dec 31, 2020
Q3 2020 -5.33 +2.03 +27.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -5.89 +0.95 +13.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -5.35 +2.68 +33.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -4.39 +5.85 +57.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -7.35 -1.03 -16.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -6.84 0 0% Apr 1, 2019 Jun 30, 2019
Q1 2019 -8.03 -3.61 -81.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -10.2 -9.45 -1196% Oct 1, 2018 Dec 31, 2018
Q3 2018 -6.33 -6.61 -2364% Jul 1, 2018 Sep 30, 2018
Q2 2018 -6.84 -9.09 -404% Apr 1, 2018 Jun 30, 2018
Q1 2018 -4.41 -7.93 -225% Jan 1, 2018 Mar 31, 2018
Q4 2017 -0.79 -3.75 -127% Oct 1, 2017 Dec 31, 2017
Q3 2017 0.28 -4.86 -94.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 2.25 -5.85 -72.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 3.52 -6.55 -65.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 2.96 -9.01 -75.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 5.14 -5.62 -52.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 8.09 +0.58 +7.72% Apr 1, 2016 Jun 30, 2016
Q1 2016 10.1 +6.57 +188% Jan 1, 2016 Mar 31, 2016
Q4 2015 12 +13.8 Oct 1, 2015 Dec 31, 2015
Q3 2015 10.8 +15.6 Jul 1, 2015 Sep 30, 2015
Q2 2015 7.51 +11.8 Apr 1, 2015 Jun 30, 2015
Q1 2015 3.49 +4.56 Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.81 -3.06 -246% Oct 1, 2014 Dec 31, 2014
Q3 2014 -4.85 -7.52 -281% Jul 1, 2014 Sep 30, 2014
Q2 2014 -4.29 -5.69 -407% Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.06 -2.56 -171% Jan 1, 2014 Mar 31, 2014
Q4 2013 1.24 +0.27 +27.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 2.68 +1.52 +132% Jul 1, 2013 Sep 30, 2013
Q2 2013 1.4 +0.94 +205% Apr 1, 2013 Jun 30, 2013
Q1 2013 1.5 +4.05 Jan 1, 2013 Mar 31, 2013
Q4 2012 0.97 +5.48 Oct 1, 2012 Dec 31, 2012
Q3 2012 1.15 Jul 1, 2012 Sep 30, 2012
Q2 2012 0.46 Apr 1, 2012 Jun 30, 2012
Q1 2012 -2.55 Jan 1, 2012 Mar 31, 2012
Q4 2011 -4.51 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.